Syngene International Ltd - 539268 - Analyst/Institutional Investor Meeting
Enclosed herewith are the details of the meeting to be held with the Analyst/Institutional Investor.13-12-2023
13-12-2023
Syngene International Ltd - 539268 - Analyst/Institutional Investor Meeting
Enclosed herewith are the details of the meeting to be held with the Analyst/Institutional Investor.11-12-2023
Syngene International Ltd - 539268 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure pursuant to Regulation 30(4) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201507-12-2023
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below the details of the meeting to be held with Analyst/Institutional investor.06-12-2023
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below the details of the meeting to be held with Analyst/Institutional investor.06-12-2023
Strides Pharma gains on transfer of Bengaluru facility to Syngene
Stelis and Syngene have executed the final agreements to transfer its Unit 3 multi-modal facility in Bengaluru to Syngene with gross consideration adjusted from Rs 702 crore to Rs 617 crore.04-12-2023
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release dated December 1, 2023.01-12-2023
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below the details of the meeting to be held with Analyst/Institutional investor.30-11-2023
Syngene International Ltd - 539268 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Regarding The Imposition Of Penalty
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 regarding the imposition of penalty.22-11-2023
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below the details of the meeting to be held with Analyst/Institutional investor.17-11-2023